Gene editing: beyond the hype
pharmaphorum
JANUARY 29, 2021
Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. It has also built its own manufacturing site and launched partnerships with six big pharma companies. Zinc fingers are the most common control gene in the body,” Macrae explains. “We
Let's personalize your content